>> EVERY NIGHT AT AROUND THIS
TIME WE BRING OUR EXPERTS TO
ANSWER OUR VIEWERS QUESTIONS
ARE QUESTIONS IN TONIGHT.
DOCTOR LARRY SLUSH UNDER THE
PRESIDENT AND CEO OF TEXAS
BIOMEDICAL RESEARCH INSTITUTE
JOINS US. I HAD AND WE
APPRECIATE YOU BEING HERE WITH
US DOCTOR AND YOU KNOW.
THERE’S SO MUCH INFORMATION
THAT’S OUT THERE THAT’S KIND OF
ONE OF THE REASONS WE DO THIS
CORONAVIRUS QNA IS TO SEPARATE
THE FACTS FROM THE FEAR AND ALL
THAT THAT OUT THERE
WHAT SHOULD PEOPLE BE LOOKING
FOR BETWEEN NOW AND THE TIME WE
ACTUALLY HAVE A VACCINE.
THAT’S READY TO GO TO MARKET, I
MEAN WHAT
IT’S KIND OF LIKE WE’RE GOING
TO HEAR ABOUT SO-CALLED MEDICAL
BREAKTHROUGHS UP WITH THAT IN
QUOTATIONS WHAT SHOULD PEOPLE
BE WARY OF AS THEY HEAR ABOUT
ALL THIS.
>> RIGHT I THINK THAT’S A GREAT
QUESTION. AND IT’S GREAT TO BE
WITH YOU THIS EVENING.
I’VE BEEN
THROUGH SEVERAL INFECTION NOT
RAISE MY CAREER OVER
30 YEARS. THE UN SPECIAL AIRS
AND A RESEARCHER OF INFECTIOUS
DISEASES. THERE ARE A COUPLE OF
DISTINGUISHING FEATURES OF THIS
PANDEMIC
THERE ARE WORTH HIGHLIGHTING
THE 24 7 NEWS CYCLE. IS RAPID
FIRE
PRODUCING A INFORMATION TO THE
PUBLIC NOT STOP AND WE’RE KIND
OF GLUED TO OUR PHONES AND OUR
IN OUR TELEVISIONS THAT YOU’RE
ABOUT ALL THIS NEWS. AND NEXT
REGRET SCIENTISTS DISCOVER
EAST POLITICS. USE IT
IN USE. THERE’S ALSO DETECTED
EQUAL WORK CARDS WHICH ARE
SPINNING AROUND THROUGHOUT
2013, WHICH IS A PUBLIC OR I OR
II WHERE
IF YOU’RE WRITING A PAPER
DEPOSITED HERE HAVE BEEN PUBLIC
YOU EVEN BEFORE EXPERIENCE PEER
REVIEWED WHICH IS THAT OUR
MONITOR ROCHE TO REALLY LOOKING
AT THE SCIENCE THAT MAKES A
DIFFERENCE SO WE’RE GETTING
DELUGED
WITH INFORMATION. AND I THINK
WE’RE REALLY GETTING TO GRIPS
LITTLE PIECES
AND PARTS. BETTER THAN ON TALK
ABOUT EXCESSIVELY ON IN THE
PUBLIC ARENA AND
AND THEIR THEIR FACTORIES
THEY’RE NOT REALLY VERY EXACT.
WE’RE HEARING THE
INFORMATION COMPANIES. SO I
THINK IT’S VERY DIFFICULT WE
GET TO A T AND I’M MY
BIGGEST CONCERN IS
POLL GET DISAPPOINTED WHEN THEY
HEAR THAT SOME THINGS ARE
PROMISING THE NEXT 8 YEARS OF
PROBLEM. CERTAINLY WE NEED TO
BE PATIENT. WE NEED TO LOOK
AT OUR PUBLICATIONS THEIR HERDS
EARLY BETTY IN A QUALITY
JOURNAL STAR
REPORTED ON YOU TALK TO EXPERTS
LIKE MYSELF IN A VERY UNCERTAIN
THIS ONE, AND WE NEED TO BE
PATIENT. WE NEED TO UNDERSTAND
THAT’S SCIENCE THAT’S BIG TIME.
IT’S A LOT OF TRIAL AND ERROR.
WE KNOW SCIENTISTS THEIRS MORE
FAIR UNDER THAT SUCCESS AND WE REALLY DO NEED TO WORK. I’M NOT
A DAY AND TO YOUR TO THINGS
LIKE DRUGS
OR VACCINES. THERE REALLY ARE
AFFECTED ON TO A LARGE AUDIENCE
SO PATIENTS KNOWLEDGE. AND A
CAREFUL LINE.
TOWARDS THESE RECORDS LAYERED
AND STORES, YEAH LET’S GET TO
SOME OF OUR VIEWER QUESTIONS
THAT THEY HAVE FOR YOU TONIGHT,
DOCTOR, THE FIRST ONE.
>> HOW LONG DOES IT USUALLY
TAKE TO DEVELOP
A VACCINE.
>> WELL JUST WHEN WE DEVELOPED
HISTORICALLY IS ABOUT 4 YEARS.
I’M TYPICALLY YOU’RE TALKING
ABOUT 10 TO
20 YEARS. TEXAS SPINE IT WE
WERE VERY INVOLVED IN THE
DEVELOPMENT OF THE EBOLA
VACCINE. THE LEADER WHICH HAS
BEEN USED IN THE CONGO RECENTLY
A SUCCESS STORY, THERE ARE
RISKS ON THE OPERATOR BEING A
POLL TO A MOSTLY OK AND THERE
WAS WORK WE WERE INVOLVED WITH.
A COMPANY FOR OVER
A DECADE. YOUR GUY WAS ALREADY
PRETTY QUICK.
SO THE IDEA THAT WE HAVE A
FULLY.
THAT’S THE NEXT ON
3 CLINICAL TRIALS.
IT’S BEEN MANUFACTURED THAT
WORKS IN THE MAJORITY OF PEOPLE
IN REMEMBER FOR COVID-19 WE’RE
TALKING TO EVERYONE ON THE
PLANET IS SO LOW SO YOU’RE
TALKING ABOUT GIVING THE
VACCINE TO GET A TRUE JUST THERE ARE PEOPLE WHO MIGHT HAVE
ORDERED SEIZES THE IDEA THAT
WILL BE THERE BY THE END OF THE
YEAR TO ME.
OUR WHOLE I THINK IT’S
VERY UNLIKELY.
I THINK THERE’S GOING TO BE
SOME PORCH OF THE ROAD THERE’S
GOING TO BE SOME SLOWDOWNS AND
IT’S GOING TO
TAKE LONGER. SO I THINK WE CAN
MOVE FASTER THAN WE
HAVE HISTORICALLY DESPITE THE
NATURE OF THESE GROUPS COMING
TOGETHER OPERATION WERE SEEN
OTHERS.
I THINK IT’S GOING TO TAKE
LONGER THAN PEOPLE THINK IT
MIGHT 6 BY 6 O’CLOCK CO ANCHOR
ISIS HAD A QUESTION THAT SHE
WAS GOING TO ASK ITS 6 O’CLOCK
IS.
>> EVEN ONCE WE GET THE
VACCINE. THAT
SEEMINGLY WORKS YOU’RE TALKING
ABOUT A MASSIVE UNDERTAKING
WHEN YOU’RE TALKING BASICALLY
EVERY COUNTRY IN THE WORLD,
EVERYBODY IN THE WORLD WATCH
ONE OF THESE VACCINES. HOW IS THAT GOING TO BE MASS PRODUCED.
>> I THINK IT’S GOING TO BE
VERY DIFFICULT ONE OF THE
ANSWERS THAT YOU HEAR IS THAT
WILL PRODUCE MORE THAN
ONE ACTUALLY, AND WE MAY FIND
OUT YOU NEED SEVERAL VACCINES
THAT TARGET
DIFFERENT POPULATIONS. THERE’S
ALSO THE ISSUE THAT THERE’S A
RACE TO VACCINE AND WE HAVE
DIFFERENT COUNTRIES
PARTICIPATING. SO THERE’S A
QUESTION OF THE HOUR. YOU KNOW
WHO WHO GETS.
YOU KNOW THE
FIRST VACCINE ARE VISITING THE
COUNTRY OF THAT DISCOVERY
ORDERS COULD BE BROADLY
DISTRIBUTED COMPANIES WILL
HARDER I TO EFFECTIVELY MAKE
THE VACCINE. I THINK THESE ARE
REALLY ON SERIOUS QUESTIONS OF
THE WE TALK ABOUT THE NUMBER OF
FIRES, THERE’S A BILLION PEOPLE
ON PLANET.
AND WE DON’T KNOW HOW MANY
DOSES ANY GIVEN INDIVIDUAL WILL
BE NECESSARY TO HAVE TO
SUSTAIN.
RESPONSE TO THE BACK SEATS ARE
THESE ART WORK
CLEARLY QUESTIONS CHALLENGES
THAT WILL FACE ALL RIGHT WANT
TO GET THROUGH AS MANY OF YOUR
QUESTIONS AS WE CAN AND.
>> YOU KNOW I ALWAYS CALL THE
SAN ANTONIO BIOMEDICAL BIOTECH
INDUSTRY, ONE OF THE
BEST CAPS 6 SECRETS, I MEAN
IT’S A HUGE SUCCESS STORY.
THE NEXT QUESTION IS HOW IS SAN
ANTONIO PLAYING A ROLE
IN DEVELOPING A VACCINE AND
ONCE WE HAVE A VACCINE WILL SAN
ANTONIO PLAY A ROLE IN TESTING
IT.
>> RIGHT
SO I I SPEAK ABOUT TEXAS BOMBER
RESEARCH INSTITUTE BECAUSE I THINK WE’LL HAVE WE HAVE OVER.
DECADES ACTUALLY PLAYED A MAJOR
ROLE IN VACCINE DEVELOPMENT
FOR EBOLA. VACCINE WE WERE VERY
INVOLVED
IN THE START I GUESS THE
VACCINE FOR ARTISTS THERE BE
STARTING THIS WORKING WHERE
THE PRIVATE SECTOR IN THE FDA
WE HAVE A LOT OF EXPERIENCE
RIGHT WE ARE COMPLETING A
MAJOR STARTING AND WHICH WE
TESTED SEVERAL OF OUR PRIMATE
SPECIES SOME
PRESIDENTIAL PRIMARY RESEARCH
CENTER TEXAS PALMER
AND WE HAVE SOME VERY PROMISING
RESULTS ON THAT YOU’LL BE
HEARING ABOUT THE NEXT COUPLE
OF WEEKS READING NOT THE FIRST
MAJOR
PAPER NOW I REALLY HAVE TO BE
THE ANIMALS ARE SUSCEPTIBLE TO
COVID-19 WE HAVE MEASURES NOW
BUT IT CAUGHT ON FIRE MANAGERS
THINGS THAT WE CAN MEASURE SO
THAT EVERY NOW GIVE THE ANIMALS
A VACCINE AND
THEN CHALLENGE THEM WITH THE
FIRES WE CAN REALLY
OBJECTIVE WE DETERMINE WHETHER
THAT ACTUALLY HURT
AND WE KNOW HOW TO DO THIS VERY
WELL WE EXPERTS IN THE
INSTITUTE ARE ALL JUST A PEOPLE
YOU’RE IN CONTRACT TALKS.
SO I THINK OUR CONTRIBUTION
CHECKS ARE GOING TO BE OUR
MERRILY IN THESE
FULLY VETTED ANIMAL MODEL
SYSTEMS AND WE’RE ALSO WORKING
WITH SMALL ANIMALS ARE USED TO
WHICH ARE ALSO GOING TO BE GOOD
MODELS TO UP BUT THROUGH A LOT
OF THERAPIES AND VACCINES AND
WE’RE GOING TO PLAY A MAJOR
ROLE, YOUR HONOR
CONFIRMING WHETHER THEIR EARLY
30’S ARE VACCINES GOING FORWARD
IN CONJUNCTION WITH
CLINICAL TRIAL. AND I THINK
THAT WOULD BE VERY IMPORTANT.
THERE
SCIENCE PROJECTS GOING ON
MEDICAL SCHOOL AT UTSA AS WELL
AS SOUTHWEST RESEARCH
INSTITUTE, NEW PRODUCTS SECOND
PRIZE A LOCAL AND OTHERS
WHO ARE PARTICIPATING IN
VARIOUS ASPECTS
OF SCIENCE WHETHER THE NEW DRUG
DISCOVERY NEW DRUG 7, 8, MAKE
IT THROUGH THE PIPELINE,
CLINICAL STUDIES WHERE
APPROVED THERAPIES LIKE
FORGET SEVERE OR PLASTIC THERE
BE ENOUGH MONEY TO CHARITY.
WHICH IS GOING ON FOR WELL SO I
THINK COLLECTIVELY WE
A LARGE ROLE TO PLAY AND THE
BEST NEWS AND I ALWAYS LIKE TO
SAY IT THIS WAY IT IS THAT ARE
WORKING TOGETHER
TO OUR ARE YOU A LIVE PICTURE OF THE CHALLENGES THE SYRINGE I
ACTUALLY MOVED.
>> WHEN WILL WE KNOW HOW LONG
RECOVERED COVID-19 PATIENTS
WILL HAVE IMMUNITY TO ONE OF
THE MANY THINGS THAT ARE GOING
ON OUT THERE.
>> RIGHT SO THESE ARE GOING TO
TAKE LONGER LONGITUDINAL
STUDIES WHERE WE REALLY LEARN
MORE ABOUT WHAT IS
YOU’RE WE MAKE A LOT OF
DIFFERENT KIND OF A BODY TO WE
HAVE TO FIND OUT EXACTLY WHICH
ONES ARE BEST ONES IN THEIR
SCIENCE FROM ALONG THERE ARE ART. WE HAVE TO LEARN WHEN AN
AND ON ONLY THROUGH ALL THE
STUDIES OVER TIME WILL WE
ULTIMATELY LEARNED ABOUT THE
DURATION THE DURABILITY OF
THOSE VIRUSES AND THAT’S A KEY
QUESTION WITH REGARD TO THE
LENGTH OF TIME THAT WE CAN
PROTECT AND EVERY INDIVIDUAL IS
PROTECTED EITHER NATURAL
COVID-19 INFECTION OR FROM ANY
VACCINE. WE ADMINISTER THAT
ABSOLUTE KEY QUESTION. AND WE
DON’T HAVE THE ANSWER TO THAT
YET.
>> DOES IT WHAT DOES IT SEEM
LIKE THAT’S ON THE SAME
TIMELINE WITH THE VACCINE.
>> I
THINK THAT YOU KNOW YOU KNOW
COME THROUGH SOME OF THE
CLINICAL TRIAL STANDS WHERE
WE’LL BE LEARNING MORE AND
MORE. BUT THOSE CITIES WILL
CONTINUE. AND THERE ARE NUMBER
OF LET S
A TERRORIST ARE THERE ARE ITEMS
A COTTAGE INDUSTRY OF TEST.
THAT ARE BEING VERY CALIBRATED
SOME WE’RE HEARING
ABOUT HER WERE ALL FALSE
POSITIVES AND FALSE NEGATIVES
WITH THEM SO THERE’S NOT REALLY
A LEAD WHEN YOU’RE TRULY
BELIEVE IN BUT I THINK THOSE
STONES ON WILL
ALLOW US I WOULD OVER TIME THE
NATURE OF THOSE ANTIBODIES AND
HOW LITTLE BIT LESS SO I THINK
THE STUDIES WILL CONTINUE AND
THE REAL
QUESTION IS WHERE WE ARE IN
FULL AND NEXT SPRING WITH
REGARD TO COVID-19 POINT TO
HAVE THERAPIES AND HAVE FOR A
LONG AS
THAT SCENE ULTIMATELY THOSE ARE
THE INTERVENTIONS THAT ARE ARE
GOING TO ENABLE US TO GO BACK
TO NORMAL LIVES AS WE WENT TO
TALK TO HER
RIGHT NEXT QUESTION CAN
SUNLIGHT KILL
THE VIRUS.
>> SEARCH NO THERE’S THERE’S A
LITTLE THERE’S SOME EVIDENCE THAT YOU’D BE LIKE. I CAN KILL.
COVID-19 WE WERE ACTUALLY ON
TESTING.
SHEEN A LOCAL COMPANY CENTER TO
WHICH IT’S A VERY HIGH
FREQUENCY ALL CITY. YOU
THE LINEUP. SO THERE
IS SOME EVIDENCE THAT YOU
RELIED HAS AN EFFECT IN BUT I
WOULD BESIDES IF YOU LIKE BEING OUTSIDE. OUTSIDE ALSO HAS
IT’S WINDY IF YOU’RE 6 FEET
APART, IT’S IT’S VERY UNLIKELY
WE’RE GOING TO TRANSMIT THE
VIRUS AND YOU KNOW WE’RE HERE
TO THE END. SO THERE’S SOME
THERE’S SOME EVIDENCE
FOR THEM.
>> AND THE FINAL QUESTION FROM
OUR VIEWERS CAN THE VIRUS BE
SPREAD THROUGH AIR CONDITIONING UNITS.
>> AND IT’S FOR A YEAR I WOULD
SAY TO THEORETICAL RISKS.
BUT THIS IS MOSTLY A
DROPLET TRANSMISSION. WHERE ARE
YOU KNOW CLOSE PROXIMITY AND
CLOSED ENVIRONMENT. IS REALLY
THE HUMAN TO IS THE MOST
EFFECTIVE WAY
TO TRANSMIT. IT CAN ONLY AFTER
SURGERY TIME ON SURFACES IN.
SO THERE’S CERTAINLY YOU’RE
WATCHING HIGH TEA MEASURES NEED
TO STAY IN PLACE.
YOU KNOW IT’S IT’S NOT WHAT I
WOULD CALL A CRIME OR
TRANSMISSION ROUTE. YEAH DOCTOR
LARRY SLASH GINGER.
>> FROM THE TEXAS BIOMEDICAL
RESEARCH INSTITUTE RIGHT HERE
IN SAN ANTONIO, I CAN’T SAY
THAT ABOUT THIS IS RESEARCH
BEING DONE RIGHT HERE IN SAN
ANTONIO. I APPRECIATE YOUR TIME TONIGHT.